SaundersC. The management of terminal malignant disease. London: Edward Arnold, 1978.
2.
MochamatCuhls HSellinJ, et al. Fatigue in advanced disease associated with palliative care: a systematic review of non-pharmacological treatments. Palliat Med2021; 35(4): 697–709.
3.
MückeMMochamatCuhlsH, et al. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev2015; 5: CD006788.
4.
GreenhalghTKnightMA’CourtC, et al. Management of post-acute covid-19 in primary care. BMJ2020; 370: m3026.
5.
AlwanNA. Track COVID-19 sickness, not just positive tests and deaths. Nature2020; 584(7822): 170.
6.
KruppLBLaRoccaNGMuir-NashJSteinbergAD. The fatigue severity scale: Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol1989; 46(10): 1121–1123.
7.
MendozaTRWangXSCleelandCS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer1999; 85(5): 1186–1196.
8.
LairdBJAScottACColvinLA, et al. Pain, depression, and fatigue as symptom cluster in advanced cancer. J Pain Sympt Manage2011; 42(1): 1–11.
SterbaKRDeVellisRFLewisMA, et al. Longitudinal psychosocial adjustment to fatigue in men with prostate cancer. Support Care Cancer2017; 25(5): 1485–1493.
11.
LillieEOPatayBDiamantJ, et al. The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Pers Med2011; 8(2): 161–173.
12.
FrankAW. The wounded storyteller: body, illness, and ethics. Chicago: The University of Chicago Press, 1995.
